✦ LIBER ✦

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

✍ Scribed by Cappuzzo, F; Toschi, L; Domenichini, I; Bartolini, S; Ceresoli, G L; Rossi, E; Ludovini, V; Cancellieri, A; Magrini, E; Bemis, L

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib in advanced non-small cell lun

✍ R. Sharma; M. Boyer; S. Clarke; M. Millward 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

EGFR / HER2 / HER3 expression in tumour

✍ Jianming Xu; Emei Gao; Yu Han; Yang Zhang; Suxia Li; Xiaoqing Liu; Zhiqiang Li; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 282 KB

EGFR mutations and HER2/3 protein expres

✍ Jian Ming Xu; Yu Han; Hai Qing Duan; E. Mei Gao; Yang Zhang; Xiao Qing Liu; Jing 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 521 KB

Gefitinib-induced acute generalized exan

✍ H-C. Shih; Y-P. Hsiao; M.F. Wu; J-H. Yang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Efficacy and tolerability of gefitinib i

✍ Cappuzzo, F; Bartolini, S; Ceresoli, G L; Tamberi, S; Spreafico, A; Lombardo, L; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Improvements of quality of life in patie

✍ Yanmei Zou; Hua Xiong; Shiying Yu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB